Acadia Pharmaceuticals Incis A Biopharmaceutical Company Based In San Diegocaliforniaspecializing In Neurosciencethe Company Develops And Commercializes Innovative Therapies For Central Nervous Systemcnsdisorderswith Additional Operations In Princetonnew Jerseyand International Offices In Denmarkswitzerlandand The Ukacadia Employs Over 500 Professionals Dedicated To Addressing Unmet Medical Needs In Neurological And Psychiatric Conditions Founded In 1993 And Publicly Traded Since 2004Acadia Is Known For Its Fda Approved Treatmentnuplazidpimavanserin Which Addresses Hallucinations And Delusions Associated With Parkinsonae S Disease Psychosisthe Company Is Also Advancing Its Pipeline With Investigations Into Schizophreniamajor Depressive Disorderand Dementia Related Psychosisas Well As Developing Trofinetide For Rett Syndromeacadia Focuses On Small Molecule Drug Discovery And Emphasizes Non Dopaminergic Mechanisms To Enhance Safety And Tolerability In Its Treatments
